DK3713942T3 - Krystallinsk 2-amino-2-(hydroxymethyl)propan-1,3-diol-salt af 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazol-5,4'-piperidin]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoesyre - Google Patents
Krystallinsk 2-amino-2-(hydroxymethyl)propan-1,3-diol-salt af 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazol-5,4'-piperidin]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoesyre Download PDFInfo
- Publication number
- DK3713942T3 DK3713942T3 DK18811658.6T DK18811658T DK3713942T3 DK 3713942 T3 DK3713942 T3 DK 3713942T3 DK 18811658 T DK18811658 T DK 18811658T DK 3713942 T3 DK3713942 T3 DK 3713942T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydrospiro
- methoxypyridin
- indazole
- piperidine
- hydroxymethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762589256P | 2017-11-21 | 2017-11-21 | |
| PCT/IB2018/058966 WO2019102311A1 (en) | 2017-11-21 | 2018-11-14 | Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3713942T3 true DK3713942T3 (da) | 2023-04-03 |
Family
ID=64559730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18811658.6T DK3713942T3 (da) | 2017-11-21 | 2018-11-14 | Krystallinsk 2-amino-2-(hydroxymethyl)propan-1,3-diol-salt af 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazol-5,4'-piperidin]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoesyre |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11325909B2 (da) |
| EP (1) | EP3713942B8 (da) |
| JP (1) | JP7237082B2 (da) |
| KR (1) | KR102395451B1 (da) |
| CN (1) | CN111406056B (da) |
| AU (1) | AU2018372109B2 (da) |
| BR (1) | BR112020008413A2 (da) |
| CA (1) | CA3082867C (da) |
| DK (1) | DK3713942T3 (da) |
| ES (1) | ES2942463T3 (da) |
| FI (1) | FI3713942T3 (da) |
| HU (1) | HUE061885T2 (da) |
| IL (1) | IL274820A (da) |
| MX (1) | MX2020005113A (da) |
| PL (1) | PL3713942T3 (da) |
| PT (1) | PT3713942T (da) |
| RU (1) | RU2020116458A (da) |
| SG (1) | SG11202003600QA (da) |
| SI (1) | SI3713942T1 (da) |
| TW (1) | TWI703143B (da) |
| WO (1) | WO2019102311A1 (da) |
| ZA (1) | ZA202002566B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202101503RA (en) | 2018-08-31 | 2021-03-30 | Pfizer | Combinations for treatment of nash/nafld and related diseases |
| US20220387402A1 (en) * | 2019-05-20 | 2022-12-08 | Pfizer Inc. | Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases |
| JP2021134211A (ja) | 2020-02-24 | 2021-09-13 | ファイザー・インク | Ｎａｆｌｄ／ｎａｓｈおよび関連疾患の処置のための組合せ |
| JP2022058085A (ja) | 2020-02-24 | 2022-04-11 | ファイザー・インク | ジアシルグリセロールアシルトランスフェラーゼ２阻害剤とアセチル－ＣｏＡカルボキシラーゼ阻害剤との組合せ |
| BR112024002129A2 (pt) | 2021-08-31 | 2024-04-30 | Pfizer | Formas sólidas de ácido 2-[(4-{6-[(4-ciano-2-fluorobenzil)óxi]piridin-2-il}piperidin-1-il)metil]-1-[(2s)-oxetan-2-ilmetil]-1h-benzimidazol-6-carboxílico, sal de 1,3-di-hidróxi-2-(hidroximetil)propan-2-amina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| CH702192A1 (de) | 2009-11-04 | 2011-05-13 | New Dent Ag | Keramisches Implantat. |
| JP5114610B1 (ja) | 2009-11-10 | 2013-01-09 | ファイザー・インク | Ｎ１−ピラゾロスピロケトンアセチル−ＣｏＡカルボキシラーゼ阻害薬 |
| PL2621493T3 (pl) | 2010-09-30 | 2017-01-31 | Pfizer Inc. | N1-pirazolospiroketonowe inhibitory karboksylazy acetylo-CoA |
| SI2632925T1 (sl) | 2010-10-29 | 2015-07-31 | Pfizer Inc. | Inhibitorji N1/N2-laktam acetil-CoA karboksilaze |
| CU24164B1 (es) * | 2011-04-22 | 2016-03-31 | Pfizer | Inhibidores sustituidos de acetil-coa carboxilasa |
-
2018
- 2018-11-14 KR KR1020207014134A patent/KR102395451B1/ko active IP Right Grant
- 2018-11-14 AU AU2018372109A patent/AU2018372109B2/en active Active
- 2018-11-14 MX MX2020005113A patent/MX2020005113A/es unknown
- 2018-11-14 RU RU2020116458A patent/RU2020116458A/ru unknown
- 2018-11-14 WO PCT/IB2018/058966 patent/WO2019102311A1/en active Application Filing
- 2018-11-14 JP JP2020545003A patent/JP7237082B2/ja active Active
- 2018-11-14 BR BR112020008413-1A patent/BR112020008413A2/pt unknown
- 2018-11-14 CA CA3082867A patent/CA3082867C/en active Active
- 2018-11-14 ES ES18811658T patent/ES2942463T3/es active Active
- 2018-11-14 US US16/765,350 patent/US11325909B2/en active Active
- 2018-11-14 SG SG11202003600QA patent/SG11202003600QA/en unknown
- 2018-11-14 EP EP18811658.6A patent/EP3713942B8/en active Active
- 2018-11-14 DK DK18811658.6T patent/DK3713942T3/da active
- 2018-11-14 PT PT188116586T patent/PT3713942T/pt unknown
- 2018-11-14 SI SI201830907T patent/SI3713942T1/sl unknown
- 2018-11-14 FI FIEP18811658.6T patent/FI3713942T3/fi active
- 2018-11-14 CN CN201880075399.6A patent/CN111406056B/zh active Active
- 2018-11-14 PL PL18811658.6T patent/PL3713942T3/pl unknown
- 2018-11-14 HU HUE18811658A patent/HUE061885T2/hu unknown
- 2018-11-16 TW TW107140741A patent/TWI703143B/zh active
-
2020
- 2020-05-08 ZA ZA2020/02566A patent/ZA202002566B/en unknown
- 2020-05-20 IL IL274820A patent/IL274820A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200074169A (ko) | 2020-06-24 |
| BR112020008413A2 (pt) | 2020-10-06 |
| WO2019102311A1 (en) | 2019-05-31 |
| CN111406056B (zh) | 2023-02-28 |
| SG11202003600QA (en) | 2020-06-29 |
| FI3713942T3 (fi) | 2023-05-04 |
| RU2020116458A (ru) | 2021-12-23 |
| SI3713942T1 (sl) | 2023-06-30 |
| IL274820A (en) | 2020-07-30 |
| TWI703143B (zh) | 2020-09-01 |
| AU2018372109B2 (en) | 2021-07-01 |
| TW201932466A (zh) | 2019-08-16 |
| PT3713942T (pt) | 2023-04-17 |
| RU2020116458A3 (da) | 2021-12-23 |
| ES2942463T3 (es) | 2023-06-01 |
| MX2020005113A (es) | 2022-05-11 |
| US20200354362A1 (en) | 2020-11-12 |
| CA3082867C (en) | 2022-05-10 |
| CA3082867A1 (en) | 2019-05-31 |
| AU2018372109A1 (en) | 2020-05-07 |
| KR102395451B1 (ko) | 2022-05-09 |
| ZA202002566B (en) | 2023-09-27 |
| PL3713942T3 (pl) | 2023-05-29 |
| CN111406056A (zh) | 2020-07-10 |
| EP3713942A1 (en) | 2020-09-30 |
| JP2021504442A (ja) | 2021-02-15 |
| US11325909B2 (en) | 2022-05-10 |
| HUE061885T2 (hu) | 2023-08-28 |
| EP3713942B1 (en) | 2023-03-08 |
| EP3713942B8 (en) | 2023-04-12 |
| JP7237082B2 (ja) | 2023-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3713942T3 (da) | Krystallinsk 2-amino-2-(hydroxymethyl)propan-1,3-diol-salt af 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazol-5,4'-piperidin]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoesyre | |
| DK3184519T3 (da) | Syreadditionssalt af trk-hæmmende forbindelse | |
| RU2566083C3 (ru) | Спироциклические производные изоксазолина в качестве противопаразитарных агентов | |
| DK3336097T3 (da) | Fremstilling af ikke-krystallinsk obeticholsyre | |
| DK3482771T3 (da) | Fremstilling af jordnøddeformuleringer til oral desensibilisering | |
| DK3046420T3 (da) | Forbedret fremgangsmåde til humanisering af animalsk skummetmælk | |
| DK2828208T3 (da) | Aktivering af persulfater med organisk syre | |
| DK3133035T3 (da) | Adsorptionskop af typen med aftagelig griber | |
| DK3149126T3 (da) | Lavmolekylære amid/ester-holdige kvaternære ammoniumsalte | |
| EA201691775A1 (ru) | Производные 1,2-дигидро-3н-пирроло[1,2-с]имидазол-3-она и их применение в качестве антибактериальных средств | |
| EA201600248A1 (ru) | Антибактериальные производные 2h-индазола | |
| DK3511396T3 (da) | Lavmolekylært imid indeholdende kvaternære ammoniumsalte | |
| HK1217331A1 (zh) | }- -氰基- -氯苯氧基 -羥基-異喹啉- -羰基 -氨基}-乙酸的晶型 | |
| BR112013007062A2 (pt) | sais de oxalato cristalinos de um composto diamídico | |
| IT201600097392A1 (it) | Metodo per la preparazione di acido 3-fluoroalchil-1-metilpirazol-4-carbossilico | |
| DK3151831T3 (da) | Priming af kræftceller med lav dosis af naltrexon | |
| EP2812314A4 (en) | AMINE SALTS OF PROSTAGLANDINE ANALOGS | |
| ZA201308160B (en) | Crystalline salts of asenapine | |
| DK3065818T3 (da) | Anordning til behandling af sygdomme i centralnervesystemet ved hjælp af sansestimulering | |
| DK2561753T3 (da) | Vandigt suspensionskoncentrat omfattende et surt salt af dodecylguanidin | |
| FR3012290B1 (fr) | Procede de preparation de sels d'acides carboxyliques herbicides | |
| DK3079474T3 (da) | Anvendelse af isoxazolinforbindelser mod parasiter | |
| EP3394070C0 (en) | CRYSTALLINE FORMS OF QUINOLIN ANALOGUES AND THEIR SALTS | |
| CO7030967A2 (es) | Método para preparar un compuesto mediante la reacción de adición de michael novedosa usando agua o varios ácidos como aditivo | |
| DK3555046T3 (da) | Blandede salte af hydroxyalkansulfinsyre |